Growth Metrics

Lucid Diagnostics (LUCD) Current Leases (2022 - 2026)

Lucid Diagnostics posted quarterly Current Leases of $908000.0 for Q1 2026, up 4.73% year-on-year from $867000.0 in Q1 2025, and up 1.68% on a QoQ basis from $893000.0 in Q4 2025.

Lucid Diagnostics (LUCD) has 5 years of Current Leases data on file, last reported at $908000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 4.73% year-over-year to $908000.0; the trailing twelve-month figure through Mar 2026 stood at $908000.0 (up 4.73% YoY), and the FY2025 full-year result was $893000.0, up 4.57% from the prior year.
  • Current Leases for Q1 2026 stood at $908000.0, up from $893000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $1.1 million in Q3 2023 and bottomed at $769000.0 in Q1 2022.
  • The 5-year median for Current Leases is $878000.0 (2025), against an average of $920235.3.
  • The widest annual swing landed in 2023, when Current Leases jumped 37.72%; it then slipped 24.2% in 2024.
  • A 5-year view of Current Leases shows it stood at $962000.0 in 2022, then advanced by 14.97% to $1.1 million in 2023, then retreated by 22.78% to $854000.0 in 2024, then climbed by 4.57% to $893000.0 in 2025, then gained by 1.68% to $908000.0 in 2026.
  • The last three Current Leases figures came in at $908000.0 (Q1 2026), $893000.0 (Q4 2025), and $878000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Lucid Diagnostics 145.00 Mn 117.12 Mn -325,000.00 908,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 908,000.00
Dec 31, 2025 893,000.00
Sep 30, 2025 878,000.00
Jun 30, 2025 871,000.00
Mar 31, 2025 867,000.00
Dec 31, 2024 854,000.00
Sep 30, 2024 855,000.00
Jun 30, 2024 884,000.00
Mar 31, 2024 861,000.00
Dec 31, 2023 1.11 Mn
Sep 30, 2023 1.13 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.05 Mn
Dec 31, 2022 962,000.00
Sep 30, 2022 860,000.00
Jun 30, 2022 798,000.00
Mar 31, 2022 769,000.00